NorthWest Biotherapeutics Inc (NWBO)

[791branko]

Umibe,

My DCVax-L survival estimates are as follows -

OS -> 1Yr, 2Yr, 3Yr, 4Yr, & 5Yr
91, 51, 32, 25, & 23

I based my control curve estimate on Rintega’s and Stupp’s Dose-Dense studies.

I suspect the actual DCVax-L control curve could thin out at the tail more than the above studies did because only NWBO tried to exclude long-term survivors (the pseudo progressors).
So I would not be surprised if my 5YrOS estimate of 23% ends up being on the low side when the unblinded data is released.